ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
To sharpen its focus on specialty chemicals, Lanxess will sell its reverse osmosis membrane business to the French firm Suez and invest in its ion-exchange resin business. Suez will get a Lanxess plant in Bitterfeld, Germany, that makes membranes to treat brackish water and seawater. Lanxess plans to spend up to $135 million to build a fourth ion-exchange resin facility within the next 5 years. The firm says the resins are used to upgrade water for applications like drug and semiconductor production.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter